BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Allergy to pollen
,
Pancreas
,
Anticancer prodrugs
,
Doxorubicin
,
rs7903146
,
PDX1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
vaccines allergies
NextBio Summary
General Info
Curated Studies
Most Correlated Studies
Peripheral blood leukocytes after rush immunotherapy
Skin biopsies from subjects with ordinary scabies
Ear tissues from mice infected epicutaneously with S. aureus
Activated follicular helper CD4 T cells versus activated non-follicular helper CD4 T cells
T follicular helper cell gene expression in clonal and non-clonal responses to LCMV infection
Explore Curated Studies Results
Literature
Most Relevant Literature
Postmarketing Safety of Vaccines Approved by the U.S. Food and Drug Administration : A Cohort Study.
COVID-19 vaccines: addressing hesitancy in young people with allergies.
Cutaneous adverse reactions of COVID-19 vaccines: A systematic review.
COVID-19 Vaccines in Children with Cow's Milk and Food Allergies.
Extension and Severity of Self-Reported Side Effects of Seven COVID-19 Vaccines in Mexican Populatio…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Effects of Diesel Exhaust Followed by Administration of Nasal Spray Flu Vaccine on Individuals With …
Safety and Immunogenicity of Pfs25M-EPA/AS01 and Pfs230D1M-EPA/AS01 Vaccines, Transmission Blocking …
Antibody Response to COVID-19 Vaccines in Liver Disease Patients
A Clinical Trial to Evaluate the Safety and Immunogenicity of BG505 MD39.3, BG505 MD39.3 gp151, and …
A Phase I, Randomized, Double-Blind, Placebo-Controlled Safety, Tolerability and Immunogenicity Stud…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ